Recent studies using in vitro RCC cells or in vivo mouse models suggested that ERβ could modulate the functions of circular RNA-ATP2B1, and long non-coding RNA-HOTAIR and consequently antagonize several miRNAs to upregulate oncogenes that promote RCC progression [79,80]. The gene discussed is ATP2B1; the disease is renal cell adenocarcinoma.